Page last updated: 2024-12-11

18-dehydroxycytochalasin h

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

18-Dehydroxycytochalasin H is a **modified form of the natural product cytochalasin H**. Cytochalasins are a family of fungal metabolites known to **inhibit actin polymerization**, a crucial process in cell motility, structure, and signaling.

Here's a breakdown of its significance in research:

**1. Structure-Activity Relationship Studies:**

* The modification of cytochalasin H to create 18-dehydroxycytochalasin H allows researchers to investigate the role of the hydroxyl group at the 18th position in its biological activity.
* Understanding how modifications in the structure affect the compound's interaction with actin can lead to **development of more potent and selective inhibitors of actin polymerization**.

**2. Potential Therapeutic Applications:**

* Cytochalasins have shown promise in various therapeutic areas, including:
* **Anti-cancer therapy:** Inhibiting actin polymerization can disrupt tumor cell invasion and metastasis.
* **Anti-inflammatory therapy:** Reducing inflammation by interfering with immune cell migration.
* **Treatment of parasitic infections:** Disrupting the actin-based cytoskeleton of parasites.
* 18-Dehydroxycytochalasin H and similar modified cytochalasins might offer improved pharmacological properties over the natural product, making them **more suitable for therapeutic applications**.

**3. Research Tools:**

* Cytochalasins, including 18-dehydroxycytochalasin H, are valuable tools for **studying cellular processes involving actin**.
* Researchers can use these compounds to **block actin polymerization in vitro and in vivo** and observe the resulting cellular effects, providing insights into actin's functions in cell division, migration, and other essential processes.

**4. Chemical Biology and Drug Discovery:**

* Understanding the mechanism of action of 18-dehydroxycytochalasin H and its analogs can lead to the design of **novel drugs that target actin polymerization** and address various unmet medical needs.
* This compound serves as a starting point for **chemical library screening** to identify new leads for drug development.

**Overall, 18-dehydroxycytochalasin H is an important research tool due to its potential applications in studying actin polymerization, developing new therapies, and exploring chemical biology and drug discovery avenues.**

18-dehydroxycytochalasin H: structure given in first source; an inhibitor of HIV-1 protease; isolated from a bark-inhabiting Ascomycete, Hypoxylon fragiforme [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID21584098
MeSH IDM0203509

Synonyms (1)

Synonym
18-dehydroxycytochalasin h
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's4 (80.00)18.2507
2000's1 (20.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]